SANOFI CONS HEALTHC IND L (SANOFICONR) - Total Liabilities
Based on the latest financial reports, SANOFI CONS HEALTHC IND L (SANOFICONR) has total liabilities worth Rs1.63 Billion INR (≈ $17.63 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
SANOFI CONS HEALTHC IND L - Total Liabilities Trend (2023–2025)
This chart illustrates how SANOFI CONS HEALTHC IND L's total liabilities have evolved over time, based on quarterly financial data. See SANOFI CONS HEALTHC IND L (SANOFICONR) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
SANOFI CONS HEALTHC IND L Competitors by Total Liabilities
The table below lists competitors of SANOFI CONS HEALTHC IND L ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Grupo Televisa S.A.B.
F:TLV
|
Germany | €122.08 Billion |
|
Sino Medical Sciences Technology In
SHG:688108
|
China | CN¥263.39 Million |
|
Tourmaline Bio Inc.
NASDAQ:TRML
|
USA | $10.10 Million |
|
Ujjivan Small Finance Bank Limited
NSE:UJJIVANSFB
|
India | Rs507.26 Billion |
|
Changzhou Tronly New Electronic Materials Co Ltd
SHE:300429
|
China | CN¥1.55 Billion |
|
Iat Automobile Technology Co Ltd
SHE:300825
|
China | CN¥887.60 Million |
|
Septerna, Inc. Common Stock
NASDAQ:SEPN
|
USA | $217.92 Million |
|
Chengdu Fusen Noble-House Industrial Co Ltd
SHE:002818
|
China | CN¥907.86 Million |
Liability Composition Analysis (2023–2025)
This chart breaks down SANOFI CONS HEALTHC IND L's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SANOFI CONS HEALTHC IND L (SANOFICONR) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.85 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SANOFI CONS HEALTHC IND L's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SANOFI CONS HEALTHC IND L (2023–2025)
The table below shows the annual total liabilities of SANOFI CONS HEALTHC IND L from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Rs1.63 Billion ≈ $17.63 Million |
+2.97% |
| 2024-12-31 | Rs1.58 Billion ≈ $17.12 Million |
+14.88% |
| 2023-12-31 | Rs1.38 Billion ≈ $14.90 Million |
-- |
About SANOFI CONS HEALTHC IND L
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was in… Read more